?ypercoagulation and myocardial injury as risk factors for mortality in patients with COVID-19 pneumonia - 12/08/21
Doi : 10.1016/j.ajem.2021.01.035
Nicholas G. Kounis a, ⁎ 
, Ioanna Koniari b, Christos Gogos c, Stelios F. Assimakopoulos d
, Ioanna Koniari b, Christos Gogos c, Stelios F. Assimakopoulos d a Department of Cardiology, University of Patras Medical School, Patras, Greece
b Department of Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
c Department of Cardiology, Papageorgiou General Hospital, Thessaloniki, Greece
d Department of Internal Medicine, University of Patras Medical School, Patras, Greece
⁎Corresponding author at: Department of Cardiology, University of Patras Medical School, Queen Olgas Square, 7, Aratou Street, Patras 26221, Greece.Department of CardiologyUniversity of Patras Medical SchoolQueen Olgas Square, 7Aratou StreetPatras26221Greece
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : Biomarkers, Covid-19, Cytokine storm, Hypercoagulation, Myocardial injury
Le texte complet de cet article est disponible en PDF.
© 2021
Elsevier Inc. Tous droits réservés.
Vol 47
P. 313-314 - septembre 2021 Retour au numéro
Article précédent
- An educational module to improve knowledge of delirium screening in the Emergency Department
- Sarah C. Minion, Brooks J. Obr, Ryan M. Carnahan, Sangil Lee
- Can on-admission anemia predict severe COVID-19 cases? A discussion about statistical and clinical significance
- Nurettin Özgür Do?an
Bienvenue sur EM-consulte, la référence des professionnels de santé.